Skip to main
EVAX

EVAX Market Capitalization Overview

Market Cap: $32.09M as of Jan 9, 2026

$32.09M
$9.80M (23.38%)past month
As of Jan 9, 2026, EVAX has a market capitalization of $32.09M. Over the past 30 days, its market cap has decreased by -13.34%, while in the last 12 months, it has increased by 6.5%.

Market capitalization represents the total value of Evaxion Biotech A/S as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

EVAX Market Cap Formula = Stock Price * Shares Outstanding

The market cap of EVAX helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

EVAX Market Cap History

DateMarket CapChange
Dec 1, 2025$34.34M-5.81%
Nov 3, 2025$36.45M+29.95%
Oct 1, 2025$28.05M+60.00%
Sep 2, 2025$17.53M+378.82%
Aug 1, 2025$3.67M+5.24%
Jul 1, 2025$3.48M-8.82%
Jun 2, 2025$3.82M+74.36%
May 1, 2025$2.19M+12.35%
Apr 1, 2025$1.95M-12.17%
Mar 3, 2025$2.22M-21.25%
Feb 3, 2025$2.82M-56.56%
Jan 2, 2025$6.49M-24.52%

EVAX End of Year Market Cap History

DateMarket CapChange
2026$32.09M+6.50%
2025$30.13M+408.20%
2024$5.93M-68.91%
2023$19.08M-53.69%
2022$41.19M-59.84%
2021$102.57M

FAQs About Evaxion Biotech A/S (EVAX) Market Cap

As of Jan 9, 2026, the market capitalization of EVAX is $32.09M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Evaxion Biotech A/S’s market capitalization has decreased by -23.38%, changing from $41.88M to $32.09M as of Jan 9, 2026.

In the last 3 months, Evaxion Biotech A/S’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Evaxion Biotech A/S’s market capitalization increased from $5.93M in January to $30.13M in December, reflecting a 408.2% change.

In the past five years, EVAX has had a compound annual growth rate (CAGR) of -21.73% in market capitalization. This means its market cap has shrunk at an average rate of -21.73% per year.

Evaxion Biotech A/S (EVAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.